Found: 19
Select item for more details and to access through your institution.
A phase I dose-escalation study of LY2875358, a bivalent MET antibody, given as monotherapy or in combination with erlotinib or gefitinib in Japanese patients with advanced malignancies.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 584, doi. 10.1007/s10637-016-0370-7
- By:
- Publication type:
- Article
Prognostic impact of EGFR/ALK alterations in leptomeningeal metastasis from lung adenocarcinoma treated with whole-brain radiotherapy.
- Published in:
- Clinical & Experimental Metastasis, 2023, v. 40, n. 5, p. 407, doi. 10.1007/s10585-023-10225-7
- By:
- Publication type:
- Article
Intracranial complete response for non-small-cell lung cancer patient with negative PD-L1 expression of the lung using nivolumab.
- Published in:
- Cancer Reports, 2022, v. 5, n. 2, p. 1, doi. 10.1002/cnr2.1460
- By:
- Publication type:
- Article
Morphological, immune and genetic features in biopsy sample associated with the efficacy of pembrolizumab in patients with non-squamous non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 4, p. 1227, doi. 10.1007/s00432-020-03413-5
- By:
- Publication type:
- Article
Clinical Impact of Gastric Acid-Suppressing Medication Use on the Efficacy of Erlotinib and Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Clinical Impact of Gastric Acid-Suppressing Medication Use on the Efficacy of Erlotinib and Gefitinib in Patients With Advanced Non—Small-Cell Lung Cancer Harboring EGFR Mutations.
- Published in:
- Clinical Lung Cancer, 2016, v. 17, n. 5, p. 412, doi. 10.1016/j.cllc.2016.01.006
- By:
- Publication type:
- Article
Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non-small cell lung cancer who are treated with neoadjuvant therapy: Identification of prognostic microenvironmental factors after chemoradiation.
- Published in:
- Pathology International, 2013, v. 63, n. 12, p. 599, doi. 10.1111/pin.12122
- By:
- Publication type:
- Article
Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 1, p. 136, doi. 10.1007/s10637-023-01411-1
- By:
- Publication type:
- Article
Pembrolizumab on pre-existing inclusion body myositis: a case report.
- Published in:
- BMC Rheumatology, 2020, v. 4, n. 1, p. N.PAG, doi. 10.1186/s41927-020-00144-5
- By:
- Publication type:
- Article
Impact of concomitant medication on clinical outcomes in patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 13, p. 1983, doi. 10.1111/1759-7714.14001
- By:
- Publication type:
- Article
Successful treatment with nivolumab for SMARCA4‐deficient non‐small cell lung carcinoma with a high tumor mutation burden: A case report.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 5, p. 1285, doi. 10.1111/1759-7714.13070
- By:
- Publication type:
- Article
Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2205, doi. 10.1007/s00262-023-03393-8
- By:
- Publication type:
- Article
Medical management of older patients with lung cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 10, p. 1082, doi. 10.1093/jjco/hyac135
- By:
- Publication type:
- Article
Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 4, p. 383, doi. 10.1093/jjco/hyab208
- By:
- Publication type:
- Article
Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 12, p. 1112, doi. 10.1093/jjco/hyx147
- By:
- Publication type:
- Article
Prognostic effects of osteoclast inhibitors in extensive stage small cell lung cancer patients with bone metastases.
- Published in:
- Molecular & Clinical Oncology, 2018, v. 9, n. 5, p. 561, doi. 10.3892/mco.2018.1710
- By:
- Publication type:
- Article
Prognostic impact and gene expression analysis of peri‐tumoral alveolar macrophage in resected lung adenocarcinoma.
- Published in:
- Cancer Science, 2023, v. 114, n. 8, p. 3423, doi. 10.1111/cas.15848
- By:
- Publication type:
- Article
Pharmacokinetic and dose‐finding study of osimertinib in patients with impaired renal function and low body weight.
- Published in:
- Cancer Science, 2023, v. 114, n. 5, p. 2087, doi. 10.1111/cas.15736
- By:
- Publication type:
- Article
Immunophenotypic features of metastatic lymph node tumors to predict recurrence in N2 lung squamous cell carcinoma.
- Published in:
- Cancer Science, 2014, v. 105, n. 7, p. 905, doi. 10.1111/cas.12434
- By:
- Publication type:
- Article